A value-based healthcare model for initiating and switching psoriasis therapies-Results from the prospective multicentre IMPROVE study.

Valdemar Wendelboe Nielsen Caecilie Bachdal Johansen Tanja Todberg Lone Skov Christoffer Valdemar NissenR DodgeAlexander Egeberg Jacob Pontoppidan Thyssen Simon Francis Thomsen

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)

The model evaluated herein is the first value-based model to calculate remuneration from patient reported outcomes and showed to successfully predict the expected PBI and remunerate treatment based on whether the expected treatment goal was met or exceeded. This can be utilized in the patient-centred management of PsO.

Keyphrases

patient reported outcomes
healthcare
clinical trial
randomized controlled trial
social media